Status:
UNKNOWN
Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients
Lead Sponsor:
Ziv Hospital
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Background: Multiple sclerosis (MS) is a complex and multifactorial neurological disease characterized by infiltration of immune cells and progressive damage to myelin and axons. Remyelination, the ge...
Detailed Description
Methods: The study will be authorized by the Ziv Helsinki Committee. Informed consent and questionnaire will obtained from all subjects before study entry. We will examine 120 volunteers in a blind fa...
Eligibility Criteria
Inclusion
- Age 18-60
Exclusion
- Other diseases, pathologies, or immune system disorders.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01918501
Start Date
August 1 2013
End Date
July 1 2015
Last Update
December 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ZIV Medical Center
Safed, Israel, 13100